Home

Specialists in the manufacture of

SOFT GELATIN CAPSULES

ABOUT US

BENEFITS OF SOFT GELATIN CAPSULES (CGB)

  • Safe

    Total security due to its inviolable content.

  • High bioavailability

    Greater and better therapeutic effect.

  • attractive

    Wide variety of shapes, sizes and colors.

  • Effective

    Rapid absorption which makes the effect of the product more effective.

  • Practice

    It offers greater uniformity and precision in doses.

  • Durable

    Improves the safety/efficacy of the active pharmaceutical ingredient.

MEXICAN PHARMACEUTICAL COMPANY

With 50 years of experience in CGB

More than 800,000,000 capsules annually position us as a leading company in the field.

QUALITY AND INNOVATION

Our manufacturing plant is equipped with cutting-edge technology that guarantees the highest quality of products.


NEWS

Esteve will invest 100 million euros in the construction of a new production unit at its Celrà plant (Girona)

Esteve has begun work to build a new manufacturing unit at its plant in Celrà (Girona).

Know more

The European generic medicines industry celebrates 30 years contributing to the health of citizens

The city of Dublin was the scene of the annual Medicines for Europe conference.

Know more

Lilly collaborates with OpenAI to discover new drugs against drug-resistant bacteria

Eli Lilly, has announced a collaboration with OpenAI to leverage artificial intelligence.

Know more

MSD launches IDEA Studios to drive healthcare innovation

The headquarters will be located in innovation centers in Europe and Asia to collaborate closely with start-ups.

Know more

Pfizer Spain collaborates with 732 research centers around the world

In Spain, it has invested 77 million euros in R&D&i in the pharmaceutical industry, 42% more than the previous year.

Know more

The turnover of the pharmaceutical industry grew by 361.7% in the first quarter of the year

In the first quarter of the year, the pharmaceutical industry reached a total turnover of 1.4 billion pesos.

Know more

The Avenzoar Foundation recognizes the career of Manuel Pérez Fernández on its 40th anniversary

This entity wanted to distinguish Pérez Fernández for leading from the start of projects.

Know more

Santen launches Roclanda in Spain, the first innovation in the medical treatment of glaucoma in Europe

This is the first treatment whose main mechanism of action is directed at trabecular meshwork dysfunction.

Know more

Normon reaches 3,000 employees, 96% of whom are permanent


Normon, has reached 3,000 professionals this April 2024.


Know more
Share by: